Cargando…
Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in the Blood as a Diagnostic Test for Infection and Infectious Viral Shedding
BACKGROUND: SARS-CoV-2 nucleocapsid antigen can be detected in plasma, but little is known about its performance as a diagnostic test for acute SARS-CoV-2 infection or infectious viral shedding among nonhospitalized individuals. METHODS: We used data generated from anterior nasal and blood samples c...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620332/ https://www.ncbi.nlm.nih.gov/pubmed/36381627 http://dx.doi.org/10.1093/ofid/ofac563 |
_version_ | 1784821324552601600 |
---|---|
author | Mathur, Sujata Davidson, Michelle C Anglin, Khamal Lu, Scott Goldberg, Sarah A Garcia-Knight, Miguel Tassetto, Michel Zhang, Amethyst Romero, Mariela Pineda-Ramirez, Jesus Diaz-Sanchez, Ruth Rugart, Paulina Chen, Jessica Y Donohue, Kevin Shak, Joshua R Chenna, Ahmed Winslow, John W Petropoulos, Christos J Yee, Brandon C Lambert, Jeremy Glidden, David V Rutherford, George W Deeks, Steven G Peluso, Michael J Andino, Raul Martin, Jeffrey N Kelly, J Daniel |
author_facet | Mathur, Sujata Davidson, Michelle C Anglin, Khamal Lu, Scott Goldberg, Sarah A Garcia-Knight, Miguel Tassetto, Michel Zhang, Amethyst Romero, Mariela Pineda-Ramirez, Jesus Diaz-Sanchez, Ruth Rugart, Paulina Chen, Jessica Y Donohue, Kevin Shak, Joshua R Chenna, Ahmed Winslow, John W Petropoulos, Christos J Yee, Brandon C Lambert, Jeremy Glidden, David V Rutherford, George W Deeks, Steven G Peluso, Michael J Andino, Raul Martin, Jeffrey N Kelly, J Daniel |
author_sort | Mathur, Sujata |
collection | PubMed |
description | BACKGROUND: SARS-CoV-2 nucleocapsid antigen can be detected in plasma, but little is known about its performance as a diagnostic test for acute SARS-CoV-2 infection or infectious viral shedding among nonhospitalized individuals. METHODS: We used data generated from anterior nasal and blood samples collected in a longitudinal household cohort of SARS-CoV-2 cases and contacts. Participants were classified as true positives if polymerase chain reaction (PCR) positive for SARS-CoV-2 and as true negatives if PCR negative and seronegative. Infectious viral shedding was determined by the cytopathic effect from viral culture. Stratified by 7 days after symptom onset, we constructed receiver operating characteristic (ROC) curves to describe optimized accuracy (Youden index), optimized sensitivity, and specificity. RESULTS: Of 80 participants, 58 (73%) were true positives while 22 (27%) were true negatives. Using the manufacturer's cutoff of 1.25 pg/mL for evaluating infection, sensitivity was higher from 0 to 7 days (77.6% [95% confidence interval {CI}, 64%–88.2%]) than from 8 to 14 days (43.2% [95% CI, 31.1%–54.5%]) after symptom onset; specificity was unchanged at 100% (95% CI, 88.1%–100%). This test had higher sensitivity (100% [95% CI, 88.4%–100%]) and lower specificity (65% [95% CI, 40.8%–84.6%]) for infectious viral shedding as compared with infection, particularly within the first week of symptom onset. Although the presence of N-antigen correlated with infectious viral shedding (r = 0.63; P < .01), sensitivity still declined over time. Additional cutoffs from ROC curves were identified to optimize sensitivity and specificity. CONCLUSIONS: We found that this SARS-CoV-2 N-antigen test was highly sensitive for detecting early but not late infectious viral shedding, making it a viable screening test for community-dwelling individuals to inform isolation practices. |
format | Online Article Text |
id | pubmed-9620332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-96203322022-11-04 Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in the Blood as a Diagnostic Test for Infection and Infectious Viral Shedding Mathur, Sujata Davidson, Michelle C Anglin, Khamal Lu, Scott Goldberg, Sarah A Garcia-Knight, Miguel Tassetto, Michel Zhang, Amethyst Romero, Mariela Pineda-Ramirez, Jesus Diaz-Sanchez, Ruth Rugart, Paulina Chen, Jessica Y Donohue, Kevin Shak, Joshua R Chenna, Ahmed Winslow, John W Petropoulos, Christos J Yee, Brandon C Lambert, Jeremy Glidden, David V Rutherford, George W Deeks, Steven G Peluso, Michael J Andino, Raul Martin, Jeffrey N Kelly, J Daniel Open Forum Infect Dis Major Article BACKGROUND: SARS-CoV-2 nucleocapsid antigen can be detected in plasma, but little is known about its performance as a diagnostic test for acute SARS-CoV-2 infection or infectious viral shedding among nonhospitalized individuals. METHODS: We used data generated from anterior nasal and blood samples collected in a longitudinal household cohort of SARS-CoV-2 cases and contacts. Participants were classified as true positives if polymerase chain reaction (PCR) positive for SARS-CoV-2 and as true negatives if PCR negative and seronegative. Infectious viral shedding was determined by the cytopathic effect from viral culture. Stratified by 7 days after symptom onset, we constructed receiver operating characteristic (ROC) curves to describe optimized accuracy (Youden index), optimized sensitivity, and specificity. RESULTS: Of 80 participants, 58 (73%) were true positives while 22 (27%) were true negatives. Using the manufacturer's cutoff of 1.25 pg/mL for evaluating infection, sensitivity was higher from 0 to 7 days (77.6% [95% confidence interval {CI}, 64%–88.2%]) than from 8 to 14 days (43.2% [95% CI, 31.1%–54.5%]) after symptom onset; specificity was unchanged at 100% (95% CI, 88.1%–100%). This test had higher sensitivity (100% [95% CI, 88.4%–100%]) and lower specificity (65% [95% CI, 40.8%–84.6%]) for infectious viral shedding as compared with infection, particularly within the first week of symptom onset. Although the presence of N-antigen correlated with infectious viral shedding (r = 0.63; P < .01), sensitivity still declined over time. Additional cutoffs from ROC curves were identified to optimize sensitivity and specificity. CONCLUSIONS: We found that this SARS-CoV-2 N-antigen test was highly sensitive for detecting early but not late infectious viral shedding, making it a viable screening test for community-dwelling individuals to inform isolation practices. Oxford University Press 2022-10-22 /pmc/articles/PMC9620332/ /pubmed/36381627 http://dx.doi.org/10.1093/ofid/ofac563 Text en Published by Oxford University Press on behalf of Infectious Diseases Society of America 2022. This work is written by (a) US Government employee(s) and is in the public domain in the US. |
spellingShingle | Major Article Mathur, Sujata Davidson, Michelle C Anglin, Khamal Lu, Scott Goldberg, Sarah A Garcia-Knight, Miguel Tassetto, Michel Zhang, Amethyst Romero, Mariela Pineda-Ramirez, Jesus Diaz-Sanchez, Ruth Rugart, Paulina Chen, Jessica Y Donohue, Kevin Shak, Joshua R Chenna, Ahmed Winslow, John W Petropoulos, Christos J Yee, Brandon C Lambert, Jeremy Glidden, David V Rutherford, George W Deeks, Steven G Peluso, Michael J Andino, Raul Martin, Jeffrey N Kelly, J Daniel Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in the Blood as a Diagnostic Test for Infection and Infectious Viral Shedding |
title | Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in the Blood as a Diagnostic Test for Infection and Infectious Viral Shedding |
title_full | Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in the Blood as a Diagnostic Test for Infection and Infectious Viral Shedding |
title_fullStr | Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in the Blood as a Diagnostic Test for Infection and Infectious Viral Shedding |
title_full_unstemmed | Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in the Blood as a Diagnostic Test for Infection and Infectious Viral Shedding |
title_short | Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in the Blood as a Diagnostic Test for Infection and Infectious Viral Shedding |
title_sort | evaluation of severe acute respiratory syndrome coronavirus 2 nucleocapsid antigen in the blood as a diagnostic test for infection and infectious viral shedding |
topic | Major Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620332/ https://www.ncbi.nlm.nih.gov/pubmed/36381627 http://dx.doi.org/10.1093/ofid/ofac563 |
work_keys_str_mv | AT mathursujata evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT davidsonmichellec evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT anglinkhamal evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT luscott evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT goldbergsaraha evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT garciaknightmiguel evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT tassettomichel evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT zhangamethyst evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT romeromariela evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT pinedaramirezjesus evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT diazsanchezruth evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT rugartpaulina evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT chenjessicay evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT donohuekevin evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT shakjoshuar evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT chennaahmed evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT winslowjohnw evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT petropouloschristosj evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT yeebrandonc evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT lambertjeremy evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT gliddendavidv evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT rutherfordgeorgew evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT deekssteveng evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT pelusomichaelj evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT andinoraul evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT martinjeffreyn evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding AT kellyjdaniel evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding |